Page last updated: 2024-08-16

ag 1879 and paclitaxel

ag 1879 has been researched along with paclitaxel in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, T; Pengetnze, Y; Taylor, CC1
Bedalov, CO; Prosperi, JR; Soto, KF; VanKlompenberg, MK1
Adachi, J; Horiuchi, M; Kuga, T; Nagano, M; Nakayama, Y; Saito, Y; Tomonaga, T; Yamaguchi, N1

Other Studies

3 other study(ies) available for ag 1879 and paclitaxel

ArticleYear
Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Caspase 3; Caspase 9; Caspases; Cisplatin; Cytochromes c; Drug Resistance, Neoplasm; Enzyme Activation; Female; Humans; Mice; Ovarian Neoplasms; Paclitaxel; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Tumor Cells, Cultured

2005
APC selectively mediates response to chemotherapeutic agents in breast cancer.
    BMC cancer, 2015, Jun-07, Volume: 15

    Topics: Adenomatous Polyposis Coli Protein; Animals; Anthracenes; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase 4; Mice; Mice, Transgenic; Paclitaxel; Pyrimidines; src-Family Kinases

2015
The tyrosine kinase v-Src causes mitotic slippage by phosphorylating an inhibitory tyrosine residue of Cdk1.
    The Journal of biological chemistry, 2018, 10-05, Volume: 293, Issue:40

    Topics: Antineoplastic Agents, Phytogenic; CDC2 Protein Kinase; Cell Proliferation; HeLa Cells; Humans; Microtubules; Mitosis; Oncogene Protein pp60(v-src); Paclitaxel; Phosphoproteins; Phosphorylation; Polyploidy; Protein Kinase Inhibitors; Pyrimidines; RNA, Small Interfering; Time-Lapse Imaging

2018